Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
10.1093/annonc/mdx419
Saved in:
Main Authors: | Nokihara, H, Lu, S, Mok, TSK, Nakagawa, K, Yamamoto, N, Shi, YK, Zhang, L, Soo, RA, Yang, JC, Sugawara, S, Nishio, M, Takahashi, T, Goto, K, Chang, J, Maemondo, M, Ichinose, Y, Cheng, Y, Lim, WT, Morita, S, Tamura, T |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Language: | English |
Published: |
OXFORD UNIV PRESS
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/218598 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
by: Yong, W.-P., et al.
Published: (2014) -
TARGETING THE PIK3 PATHWAY IN NON-SMALL CELL LUNG CANCER
by: DANIEL TAN SHAO WENG
Published: (2017) -
Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer
by: Tan, E.-H., et al.
Published: (2014) -
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
by: Millward, M.J., et al.
Published: (2016) -
The IκB kinase inhibitor ACHP targets the STAT3 signaling pathway in human non-small cell lung carcinoma cells
by: Lee, J.H., et al.
Published: (2021)